tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Sanofi’s Promising Phase 2a Study: A Potential Game-Changer in Nephrology
PremiumCompany AnnouncementsSanofi’s Promising Phase 2a Study: A Potential Game-Changer in Nephrology
4d ago
Sanofi’s Phase 3 Study on Belumosudil for Chronic GVHD: A Market Game-Changer?
Premium
Company Announcements
Sanofi’s Phase 3 Study on Belumosudil for Chronic GVHD: A Market Game-Changer?
4d ago
Sanofi’s Strategic Acquisition of Vicebio Enhances Vaccine Portfolio and Supports Buy Rating
Premium
Ratings
Sanofi’s Strategic Acquisition of Vicebio Enhances Vaccine Portfolio and Supports Buy Rating
5d ago
Sanofi’s Chlamydia Vaccine Study: A Promising Step Forward
PremiumCompany AnnouncementsSanofi’s Chlamydia Vaccine Study: A Promising Step Forward
8d ago
Sanofi’s Innovative Approach in Type 1 Diabetes Treatment: A Clinical Study Update
Premium
Company Announcements
Sanofi’s Innovative Approach in Type 1 Diabetes Treatment: A Clinical Study Update
11d ago
Sanofi’s New Study on Lunsekimig for Chronic Rhinosinusitis: A Potential Game Changer?
Premium
Company Announcements
Sanofi’s New Study on Lunsekimig for Chronic Rhinosinusitis: A Potential Game Changer?
11d ago
Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis
PremiumCompany AnnouncementsRegeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game-Changer for Chronic Rhinosinusitis
12d ago
Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game Changer for Chronic Rhinosinusitis
Premium
Company Announcements
Regeneron and Sanofi’s Phase 3 Study on Itepekimab: A Potential Game Changer for Chronic Rhinosinusitis
12d ago
Sanofi’s Promising Ulcerative Colitis Study: A Potential Game-Changer?
Premium
Company Announcements
Sanofi’s Promising Ulcerative Colitis Study: A Potential Game-Changer?
12d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100